Funding fuels Nix's next phase of growth, including the development of Nix Health - proprietary hydration algorithms built on the most comprehensive real-world hydration dataset ever assembled.

BOSTON, Sept. 15, 2026 /PRNewswire/ -- Nix Biosensors, the leading provider of real-time hydration monitoring technology, today announced the close of its $10M Series A, bringing total funding to $17 million. Investors include Shorewind Capital, Great Oaks Venture Capital, and White Road Investments (family office of CLIF Bar founders); Anne Wojcicki (23andMe); Len Blavatnik (Warner Music Group); and owners of the St. Louis Blues, Boston Celtics, Baltimore Orioles, Boston Legacy FC, and the Texas Rangers, among others.

Originally published on the BLOX Digital Content Exchange.